businesspress24.com - Prior CEOs of Monsanto and Pfizer Join Intrexon Board of Directors
 

Prior CEOs of Monsanto and Pfizer Join Intrexon Board of Directors

ID: 1060544

(firmenpresse) - BLACKSBURG, VA -- (Marketwire) -- 11/28/11 -- Intrexon Corporation, a privately held engineering company, today announced the appointments of Robert B. Shapiro and Jeffrey B. Kindler to the Intrexon Board of Directors.

Mr. Shapiro brings extensive experience in the biochemical and biological sciences industry where he served as former Vice President, President, and CEO of Monsanto, in addition to serving as Chairman and CEO of the NutraSweet subsidiary of GD Searle & Company. He received a B.A. from Harvard University in 1959 and J.D. from Columbia University School of Law in 1962.

Mr. Kindler joins the Intrexon Board following his immediate past tenure as Chairman and CEO of Pfizer, Inc. Preceding his leadership of Pfizer, Mr. Kindler served as the Executive Vice President and General Counsel of McDonald's Corporation. He received a B.A. from Tufts University in 1977, followed by a J.D. magna cum laude from Harvard University in 1980.

Intrexon's Chairman and CEO Randal J. Kirk welcomes Mr. Shapiro and Mr. Kindler stating, "Intrexon has reached a strategic execution phase that will be greatly enhanced by guidance from Bob and Jeff. I am very pleased that executives of this caliber and experience have accepted our invitation and look forward to gaining the full benefit of their experience and insights."

Intrexon Corporation is a privately held biotechnology company focused on the industrial engineering of synthetic biology. Intrexon is deploying its extensive engineering platform and capabilities to rapidly design and produce novel biofunctions and applications for , , , , and . The company's advanced industrial engineering platform enables ™ technology by combining revolutionary DNA control systems with corresponding advancements in modular transgene design, assembly and optimization. More information about the company is available at .



Contact:
Andrew Udell
Intrexon Corporation
Phone: 301-556-9850




E-mail:


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Metrasens and Invivo Sign Distribution Agreement for US Market
Horizon Pharma Announces U.S. Food and Drug Administration Acceptance of LODOTRA(R) New Drug Application for Review for the Treatment of Rheumatoid Arthritis
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 28.11.2011 - 06:00 Uhr
Sprache: Deutsch
News-ID 1060544
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

BLACKSBURG, VA


Phone:

Kategorie:

Healthcare


Anmerkungen:


Diese Pressemitteilung wurde bisher 166 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Prior CEOs of Monsanto and Pfizer Join Intrexon Board of Directors
"
steht unter der journalistisch-redaktionellen Verantwortung von

Intrexon Corporation (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Intrexon Corporation



 

Who is online

All members: 10 578
Register today: 0
Register yesterday: 4
Members online: 0
Guests online: 143


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.